Loading…
Humana Inc. is projected to rise to $492.96 by 2027, a +26% move from its current price of $392.22. HUM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $385.24 | $392.48 | $399.85 | +0.07% |
| Jul 15 | $382.53 | $392.73 | $403.21 | +0.13% |
| Jul 16 | $380.53 | $392.99 | $405.86 | +0.20% |
| Jul 17 | $378.88 | $393.25 | $408.16 | +0.26% |
| Jul 18 | $377.47 | $393.51 | $410.22 | +0.33% |
| Jul 19 | $376.22 | $393.76 | $412.13 | +0.39% |
| Jul 20 | $375.09 | $394.02 | $413.90 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $375.09 | $394.02 | $413.90 | +0.46% |
| Week 2 | $369.21 | $395.83 | $424.37 | +0.92% |
| Week 3 | $365.14 | $397.65 | $433.04 | +1.38% |
| Week 4 | $362.01 | $399.47 | $440.81 | +1.85% |
| Week 5 | $359.47 | $401.31 | $448.01 | +2.32% |
| Week 6 | $357.35 | $403.15 | $454.82 | +2.79% |
| Week 7 | $355.54 | $405.00 | $461.34 | +3.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Humana Inc. is a healthcare company listed with the symbol HUM that provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.
The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. The CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions.
Humana Inc. is a healthcare company with current price data and a substantial market footprint. It is ranked 319 and has a market cap of $49.16B. The current price stands at $409.42.
The stock sits within a forecast that envisions a bullish trajectory over multiple years, with the average price rising well beyond today’s level in the years ahead. The structure of the forecast shows notable upside across 2027, 2028, and beyond, culminating in a multi-year, large-scale upside by 2050.
A major floor 58.3% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
The nearest ceiling, 4.4% above — a clean break opens room to run.
A major ceiling 20.6% above — clearing it would confirm fresh momentum.
Key HUM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HUM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $394.75 | Sell | $394.57 | Sell |
| MA 10 | $394.99 | Sell | $391.02 | Buy |
| MA 20 | $381.38 | Buy | $378.55 | Buy |
| MA 50 | $331.65 | Buy | $335.99 | Buy |
| MA 100 | $259.06 | Buy | $295.74 | Buy |
| MA 200 | $256.29 | Buy | $272.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.96 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 53.10 | Neutral |
| Williams %R (14) | -34.20 | Info |
| MACD (12,26,9) | -2.24 | Sell |
| ROC (12) | 9.21 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 65.80 | Neutral |
| TRIX (15) | 0.90 | Buy |
| Awesome (5,34) | 35.29 | Buy |
| Ultimate (7,14,28) | 55.36 | Neutral |
| Momentum (10) | 16.22 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 394.71 | Sell |
| ADX (14) | 48.57 | Buy |
| ATR (14) | 5.78 | Info |
Sentiment is BULLISH. The RSI14 is 80, and the stock trades above both the SMA50 of $310.60 and the SMA200 of $252.40. The listed support is $301.69 and the resistance is $409.42. The 30-day range runs from $356.83 to $469.76, signaling near-term upside potential while presenting a defined upper bound near the current price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $163.67 | $392.22 | $530.85 | 0% | Neutral | |
| $403.77 | $492.96 | $629.22 | +26% | Bullish | |
| $484.21 | $602.29 | $789.58 | +54% | Bullish | |
| $591.43 | $747.02 | $1,000.19 | +90% | Bullish | |
| $699.42 | $895.35 | $1,220.40 | +128% | Bullish | |
| $863.40 | $1,118.77 | $1,549.04 | +185% | Bullish | |
| $972.58 | $1,274.48 | $1,789.75 | +225% | Bullish | |
| $1,014.35 | $1,343.22 | $1,910.72 | +242% | Bullish | |
| $1,147.36 | $1,534.48 | $2,208.87 | +291% | Bullish | |
| $1,254.95 | $1,694.25 | $2,466.00 | +332% | Bullish | |
| $2,129.30 | $2,998.30 | $4,573.38 | +664% | Bullish | |
| $4,690.27 | $7,083.23 | $11,581.43 | +17.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $163.67 | $392.22 | $477.37 | +0.00% |
| August 2026 | $356.22 | $416.88 | $498.36 | +6.29% |
| September 2026 | $354.04 | $416.34 | $501.63 | -0.13% |
| October 2026 | $356.52 | $420.99 | $510.61 | +1.12% |
| November 2026 | $364.99 | $432.50 | $527.48 | +2.73% |
| December 2026 | $364.27 | $433.04 | $530.85 | +0.13% |
Click any year to see its month-by-month HUM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Humana Inc.'s 2026 outlook centres on $392.22, within a $163.67 to $530.85 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, HUM could reach as high as $629.22, with a base case around $492.96 and support toward $403.77 — roughly +26% from $392.22. Momentum favours further upside here.
Expect HUM to range from $484.21 to $789.58 through 2028. The $602.29 average target implies a +54% move from current prices. That is up +22% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The HUM price prediction for 2029 points to an average of $747.02 (low $591.43, high $1,000.19) — a potential gain of +90% on today's $392.22. Momentum favours further upside here.
In 2030, HUM is projected to trade between $699.42 and $1,220.40, averaging $895.35 — a potential gain of +128% from today's $392.22. That is up +20% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Humana Inc.'s 2031 outlook centres on $1,118.77, within a $863.40 to $1,549.04 range. That is up +25% on the projected 2030 average. That marks a +185% change versus current levels. Momentum favours further upside here.
By 2032, HUM could reach as high as $1,789.75, with a base case around $1,274.48 and support toward $972.58 — roughly +225% from $392.22. Buyers look set to stay in control over this stretch.
Expect HUM to range from $1,014.35 to $1,910.72 through 2033. The $1,343.22 average target implies a +242% move from current prices. That is up +5% on the projected 2032 average. Momentum favours further upside here.
The HUM price prediction for 2034 points to an average of $1,534.48 (low $1,147.36, high $2,208.87) — a potential gain of +291% on today's $392.22. Buyers look set to stay in control over this stretch.
In 2035, HUM is projected to trade between $1,254.95 and $2,466.00, averaging $1,694.25 — a potential gain of +332% from today's $392.22. That is up +10% on the projected 2034 average. Momentum favours further upside here.
Humana Inc.'s 2040 outlook centres on $2,998.30, within a $2,129.30 to $4,573.38 range. That is up +77% on the projected 2035 average. That marks a +664% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, HUM could reach as high as $11,581.43, with a base case around $7,083.23 and support toward $4,690.27 — roughly +17.1x from $392.22. Momentum favours further upside here.
Investing $1,000 in HUM today (≈ 2.54959 HUM) could be worth
$18,059.33
+$17,059.33 (+1706%) by 2050 · US Dollar
Based on the average projected HUM price of $7,083.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HUMwould be worth at today's price.
$1,000 invested in HUM on Jul 10, 2025 (≈ 4.307003 HUM) would be worth
$1,689.29
+$689.29 (+68.9%) today · 1.69× · US Dollar
Based on a HUM entry price of $232.18 vs. today's $392.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $396.75 | $988.58 | -1.1% |
| 1 month ago | $364.46 | $1,076.17 | +7.6% |
| 3 months ago | $192.15 | $2,041.22 | +104.1% |
| 6 months ago | $276.59 | $1,418.06 | +41.8% |
| 1 year ago | $232.18 | $1,689.29 | +68.9% |
| All time (5.0y) ago | $460.11 | $852.45 | -14.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HUM forecast.
Our base-case forecast reaches $780.00 around 2030.
Implied market cap at $780.00: $93.65B
The multi-year forecast shows a steady upside path with the 2026 average price at $409.42 and a bullish cadence thereafter. By 2027 the average is $517.88 with a 26.5% ROI, followed by 2028 at $627.56 (53.3%), 2029 at $768.23 (87.6%), and 2030 at $930.23 (127.2%). The outlook remains bullish through 2031 ($1,153.16, 181.7%), 2032 ($1,296.01, 216.6%), 2033 ($1,370.58, 234.8%), 2034 ($1,563.14, 281.8%), and 2035 ($1,720.87, 320.3%).
In the longer term, 2040 is forecast at $3,033.97 (641%), and 2050 at $7,001.51 (1610.1%). These figures reflect a bullish sentiment across the horizon, with substantial upside potential, though they are estimates and not guarantees. Drivers and risks are not specified in the forecast, and actual results can differ.
Tap a question to reveal the answer.
Avg $930.23; min $717.53; max $1,288.83; ROI 127.2%; sentiment bullish.
Forecast shows bullish sentiment from 2027 onward with rising Avg prices and positive ROI (2027 Avg $517.88, ROI 26.5%; 2028 Avg $627.56, ROI 53.3%; 2029 Avg $768.23, ROI 87.6%; 2030 Avg $930.23, ROI 127.2%; 2031 Avg $1,153.16, ROI 181.7%; 2032 Avg $1,296.01, ROI 216.6%; 2033 Avg $1,370.58, ROI 234.8%; 2034 Avg $1,563.14, ROI 281.8%; 2035 Avg $1,720.87, ROI 320.3%; 2040 Avg $3,033.97, ROI 641%; 2050 Avg $7,001.51, ROI 1610.1%).
Yes. The forecast max in 2029 is $1,043.94 and in 2030 is $1,288.83.
$49.16B.
Humana Inc. Community Discussion
0Share your Humana Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.